Sepulveda Carlos M
Sepulveda Carlos M's purchase track record
How the stock did after each of Sepulveda Carlos M's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/22/2025 | TFIN | $335K | +29.1% | +23.9% | +27.4% |
| 8/23/2023 | TFIN | $148K | +9.7% | +18.9% | +12.3% |
| 6/6/2023 | TFIN | $106K | +8.8% | +20.7% | +6.6% |
| 5/8/2023 | TFIN | $383K | +44.0% | +39.7% | +5.5% |
| 1/30/2023 | TFIN | $2.56M | -6.2% | +29.8% | +14.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Triumph Financial downgraded as analysts call it overpriced. Triumph Financial was downgraded in a recent Seeking Alpha note that described the stock as overpriced even if economic conditions remain stable. The downgrade adds to a broader mixed view of financial stocks, with some benefiting from higher cash yields while many U.S. banks saw lower prices in September. The stock is trading near its long‑term support level, and its high trailing P/E suggests valuation concerns remain.
Transaction History
| CNK | ▲ Buy | Grant | 5,439 | $0 | 6/15/2026 | View on chart |
| TFIN | ▲ Buy | Grant | 1,628 | $0 | 5/1/2026 | View on chart |
| TFIN | ▲ Buy | Grant | 857 | $0 | 7/1/2025 | View on chart |
| CNK | ▲ Buy | Grant | 4,200 | $0 | 6/13/2025 | View on chart |
| TFIN | ▲ Buy | Open Market | 6,765 | $322K | 4/22/2025 | View on chart |
| TFIN | ▲ Buy | Open Market | 265 | $13K | 4/22/2025 | View on chart |
| TFIN | ▲ Buy | Grant | 690 | $0 | 2/3/2025 | View on chart |
| TFIN | ▼ Sell | Gift | 9,232 | $0 | 7/26/2024 | View on chart |
| TFIN | ▲ Buy | Grant | 748 | $0 | 7/1/2024 | View on chart |
| CNK | ▲ Buy | Grant | 7,364 | $0 | 6/14/2024 | View on chart |
| TFIN | ▼ Sell | Open Market | 16,000 | $1.1M | 4/29/2024 | View on chart |
| TFIN | ▲ Buy | Grant | 859 | $0 | 2/1/2024 | View on chart |
| TFIN | ▼ Sell | Open Market | 13,500 | $1.0M | 12/14/2023 | View on chart |
| TFIN | ▼ Sell | Gift | 5,000 | $0 | 11/28/2023 | View on chart |
| TFIN | ▼ Sell | Open Market | 21,500 | $1.5M | 11/21/2023 | View on chart |
| TFIN | ▼ Sell | Gift | 5,617 | $0 | 10/25/2023 | View on chart |
| TFIN | ▲ Buy | Open Market | 7,400 | $148K | 8/23/2023 | View on chart |
| TFIN | ▲ Buy | Grant | 897 | $0 | 7/3/2023 | View on chart |
| CNK | ▲ Buy | Grant | 7,867 | $0 | 6/15/2023 | View on chart |
| TFIN | ▲ Buy | Open Market | 1,526 | $30K | 6/9/2023 | View on chart |
| TFIN | ▲ Buy | Open Market | 1,756 | $35K | 6/7/2023 | View on chart |
| TFIN | ▲ Buy | Open Market | 2,116 | $41K | 6/6/2023 | View on chart |
| TFIN | ▲ Buy | Open Market | 7,835 | $383K | 5/8/2023 | View on chart |
| TFIN | ▲ Buy | Grant | 942 | $0 | 2/1/2023 | View on chart |
| TFIN | ▲ Buy | Open Market | 47,000 | $2.6M | 1/30/2023 | View on chart |
| TFIN | ▲ Buy | Grant | 1,098 | $0 | 7/1/2022 | View on chart |
| CNK | ▲ Buy | Grant | 8,406 | $0 | 6/15/2022 | View on chart |
| TFIN | ▲ Buy | Grant | 817 | $0 | 2/1/2022 | View on chart |
| TFIN | ▼ Sell | Open Market | 14,974 | $2.0M | 11/17/2021 | View on chart |
| TFIN | ▼ Sell | Gift | 12,000 | $0 | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cinemark stock rises on ScreenX expansion and higher Q3 revenue forecasts
Cinemark shares have gained 7.5% following announcements of ScreenX expansion and increased third-quarter revenue forecasts. The stock has also risen 12% over the past month, with analysts noting its premium format growth. Current trading levels remain below the average analyst target price of $40.27.
Cinemark stock rises on ScreenX expansion and higher Q3 revenue forecasts. Cinemark shares have gained 7.5% following announcements of ScreenX expansion and increased third-quarter revenue forecasts. The stock has also risen 12% over the past month, with analysts noting its premium format growth. Current trading levels remain below the average analyst target price of $40.27.